Published on | 1 year ago
Programmes Horizon EuropeOn 20 March, the Commission adopted the 2nd Strategic Plan for Horizon Europe. It sets out three key strategic orientations for the EU's research & innovation funding for the three last years of the programme (2025-2027):
These key strategic orientations are the guiding principles for Horizon Europe and will be implemented through the work programmes. In the next months, the main Horizon Europe Work Programme 2025 will be developed following these orientations.
The newly adopted plan has the following overarching principles: open strategic autonomy and securing Europe's leading role in developing and deploying critical technologies.
In addition, the strategic plan:
More information is available on the dedicated Commission website, including a press release, the full text of the Horizon Europe strategic plan 2025-2027 (text) and a summary factsheet.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.